Structure-activity relationship studies for inhibitors for vancomycin-resistant

Acetazolamide Anti-Bacterial Agents / pharmacology Carbonic Anhydrase Inhibitors / pharmacology Carbonic Anhydrases / chemistry Enterococcus faecalis Gram-Positive Bacterial Infections / microbiology Humans Microbial Sensitivity Tests Structure-Activity Relationship Vancomycin / pharmacology Vancomycin-Resistant Enterococci
Carbonic anhydrase inhibitors antibiotics drug repurposing vancomycin-resistant Enterococcus

Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2022
Historique:
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 29 6 2022
Statut: ppublish

Résumé

Vancomycin-resistant enterococci (VRE), consisting of pathogenic

Identifiants

DOI: 10.1080/14756366.2022.2092729 PMID: 35758212 PMC: PMC9246096
pubmed: 35758212
doi: 10.1080/14756366.2022.2092729
pmc: PMC9246096
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbonic Anhydrase Inhibitors 0
Vancomycin 6Q205EH1VU
Carbonic Anhydrases EC 4.2.1.1
Acetazolamide O3FX965V0I

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1838-1844

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI148523
Pays : United States

Références

J Med Chem. 2016 Dec 22;59(24):11098-11109
pubmed: 28002963
Biochem J. 2016 Jul 15;473(14):2023-32
pubmed: 27407171
Clin Microbiol Rev. 1990 Jan;3(1):46-65
pubmed: 2404568
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1061-1066
pubmed: 34030562
J Exp Med. 1899 Sep 1;4(5-6):521-34
pubmed: 19866921
J Med Chem. 2019 Apr 11;62(7):3184-3205
pubmed: 30404451
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1060-1068
pubmed: 32314608
Clin Infect Dis. 2009 Jan 1;48(1):1-12
pubmed: 19035777
ACS Infect Dis. 2021 Jul 9;7(7):1969-1984
pubmed: 33765392
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
J Enzyme Inhib Med Chem. 2021 Dec;36(1):372-376
pubmed: 33390061
Bacteriol Rev. 1937 Dec;1(1):3-97
pubmed: 16350049
Bioorg Med Chem Lett. 2014 Jan 1;24(1):240-4
pubmed: 24316122
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14
pubmed: 23221186
Nat Rev Microbiol. 2012 Mar 16;10(4):266-78
pubmed: 22421879
FEMS Microbiol Rev. 2000 Oct;24(4):335-66
pubmed: 10978542
Nucleic Acids Res. 2014;42(16):10579-95
pubmed: 25143534
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28264856
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
J Med Chem. 2006 Mar 23;49(6):2117-26
pubmed: 16539401
J Med Chem. 2020 Sep 10;63(17):9540-9562
pubmed: 32787141
Bioorg Med Chem Lett. 2005 Jan 17;15(2):367-72
pubmed: 15603956
J Enzyme Inhib Med Chem. 2016 Dec;31(6):894-9
pubmed: 26607399
Curr Pharm Des. 2017;23(14):2147-2157
pubmed: 28190396

Auteurs

Weiwei An (W)

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.

Katrina J Holly (KJ)

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.
ORCID: 0000-0002-5193-4503

Alessio Nocentini (A)

Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, Italy.
ORCID: 0000-0003-3342-702X

Ryan D Imhoff (RD)

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.
ORCID: 0000-0002-8510-8437

Chad S Hewitt (CS)

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.

Nader S Abutaleb (NS)

Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
Center for Emerging, Zoonotic and Arthropod-Borne Pathogens, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.

Xufeng Cao (X)

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.

Mohamed N Seleem (MN)

Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, Italy.
Center for Emerging, Zoonotic and Arthropod-Borne Pathogens, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
ORCID: 0000-0003-0939-0458

Claudiu T Supuran (CT)

Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
ORCID: 0000-0003-4262-0323

Daniel P Flaherty (DP)

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.
Purdue Institute for Drug Discovery, West Lafayette, IN, USA.
Purdue Institute of Inflammation, Immunology and Infectious Disease, West Lafayette, IN, USA.
ORCID: 0000-0002-8305-0606

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Thiazoles › Thiadiazoles › Acétazolamide › Structure-activity relationship studies for...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Structure-activity relationship studies for...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Inhibiteurs de l'anhydrase carbonique › Structure-activity relationship studies for...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Lyases › Carbon-oxygen lyases › Hydro-lyases › Carbonic anhydrases › Structure-activity relationship studies for...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Enterococcaceae › Enterococcus › Enterococcus faecalis › Structure-activity relationship studies for...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Structure-activity relationship studies for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Structure-activity relationship studies for...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Structure-activity relationship studies for...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Relation structure-activité › Structure-activity relationship studies for...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Glycopeptides › Vancomycine › Structure-activity relationship studies for...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Enterococcaceae › Enterococcus › Entérocoques résistants à la vancomycine › Structure-activity relationship studies for...